[go: up one dir, main page]

UA95239C2 - Макроциклические ингибиторы вируса гепатита с - Google Patents

Макроциклические ингибиторы вируса гепатита с

Info

Publication number
UA95239C2
UA95239C2 UAA200714714A UAA200714714A UA95239C2 UA 95239 C2 UA95239 C2 UA 95239C2 UA A200714714 A UAA200714714 A UA A200714714A UA A200714714 A UAA200714714 A UA A200714714A UA 95239 C2 UA95239 C2 UA 95239C2
Authority
UA
Ukraine
Prior art keywords
inhibitors
hepatitis
virus
hcv
formula
Prior art date
Application number
UAA200714714A
Other languages
English (en)
Ukrainian (uk)
Inventor
Кок Герман Августинус Де
Пьер Жан-Мари Бернар Рабуассон
Кеннет Алан Симмен
Матс Стефан Линдстром
Пиа Сесилия Канберг
Дмитрий Антонов
Карл Магнус Нилссон
Бенгт Бертил Самуэльссон
Эса Анника Кристина Розенквист
Original Assignee
Тиботек Фармасьютикелз Лтд.
Медивир Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тиботек Фармасьютикелз Лтд., Медивир Аб filed Critical Тиботек Фармасьютикелз Лтд.
Publication of UA95239C2 publication Critical patent/UA95239C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UAA200714714A 2005-07-29 2006-07-28 Макроциклические ингибиторы вируса гепатита с UA95239C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05107066 2005-07-29

Publications (1)

Publication Number Publication Date
UA95239C2 true UA95239C2 (ru) 2011-07-25

Family

ID=35601774

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200714714A UA95239C2 (ru) 2005-07-29 2006-07-28 Макроциклические ингибиторы вируса гепатита с

Country Status (4)

Country Link
AP (1) AP2387A (ru)
ES (1) ES2360417T3 (ru)
UA (1) UA95239C2 (ru)
ZA (1) ZA200800856B (ru)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA74546C2 (en) * 1999-04-06 2006-01-16 Boehringer Ingelheim Ca Ltd Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition
EP1713822B1 (en) * 2004-01-30 2010-03-17 Medivir AB Hcv ns-3 serine protease inhibitors

Also Published As

Publication number Publication date
AP2387A (en) 2012-03-26
ES2360417T3 (es) 2011-06-03
ZA200800856B (en) 2009-06-24

Similar Documents

Publication Publication Date Title
SG163610A1 (en) Macrocyclic inhibitors of hepatitis c virus
MY164469A (en) Hcv ns3 protease inhibitors
SG164376A1 (en) Hcv ns3 protease inhibitors
NO20081071L (no) Makrocykliske inhibitorer av hepatitt C virus
NO20081073L (no) Makrocykliske inhibitorer av hepatitt C virus
WO2006119061A3 (en) Hcv ns3 protease inhibitors
TW200615275A (en) Hepatitis C inhibitor dipeptide analogs
UA83046C2 (ru) Соединения как ингибиторы вируса гепатита с, фармацевтическая композиция на их основе
WO2005035525A3 (en) 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease
MX2009009174A (es) Inhibidores de serina-proteasas para el tratamiento de infecciones por el virus de hepatitis c.
EA200970493A1 (ru) Макроциклические ингибиторы вируса гепатита с
TW200639169A (en) Bicyclic heteroaryl derivatives for treating viruses
MX2009003739A (es) Derivados de hidrobenzamida como inhibidores de hsp90.
UA89040C2 (ru) Замещенные глюкопиранозилом бензольные производные, лекарственное средство, которое содержит эти соединения
WO2008046860A3 (en) Bioavailable combinations for hcv treatment
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
WO2005003087A3 (en) Oxazole derivatives as antibacterial agents
WO2008038092A3 (en) Substituted piperidinophenyl oxazolidinones
UA95239C2 (ru) Макроциклические ингибиторы вируса гепатита с
MXPA05005256A (es) Nuevos compuestos de pirrolidina y tiazolidina, un proceso para su preparacion y composiciones farmaceuticas que los contienen.
UA90909C2 (en) Hcv ns3 protease inhibitors
TW200624429A (en) Novel cysteine protease inhibitors
IL205083A0 (en) Process for the preparation of tetranorlabdane derivatives
WO2007004041A3 (en) New compounds and their pharmaceutical use
ATE405588T1 (de) Analoge des somatostatin